Tags : Medicilon

Medicilon interviewed Academician Biao Jiang | Co-founded Gluetacs Therapeutics to transform the sci

Medicilon interviewed Academician Biao Jiang | Co-..

A Story by Medicilon


Shanghai Medicilon Inc (Medicilon) interviewed Academician Jiang to see how he overcomes the problems of transformation of scientific and technologica..
Medicilon interview with Dr. Fei Zhang | Walking in the dark with a light, Raymon Pharma's new medic

Medicilon interview with Dr. Fei Zhang | Walking i..

A Story by Medicilon


The innovative ophthalmic drugs self-developed by Raymon Pharma have continuously achieved new breakthroughs, which is a strong evidence of the contin..
Medicilon interview with Dr. Xin Dong - In the field of immunotherapy, where the fierce competition

Medicilon interview with Dr. Xin Dong - In the fie..

A Story by Medicilon


To this end, Shanghai Medicilon Inc. (Medicilon) interviewed Dr. Xin Dong to get a glimpse of his profound insights in the field of immunotherapy, and..
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug resea

Fosun Health Capital reached a cooperation agreeme..

A Story by Medicilon


On July 25, 2023, Fosun Health Capital established by Fosun Pharma（stock code:600196.SH), reached a strategic partnership with Medicilon（..
Medicilon Assists ABM Therapeutics to Obtain US FDA Orphan Drug Qualification for ABM-1310 for the T

Medicilon Assists ABM Therapeutics to Obtain US FD..

A Story by Medicilon


Shanghai, China/San Diego,USA - August 2, 2023, ABM Therapeutics announced that its self-developed small molecule BRAF inhibitor ABM-1310 has obtained..
Medicilon signed a strategic collaboration agreement with the North American 100 Angel Investment

Medicilon signed a strategic collaboration agreeme..

A Story by Medicilon


Medicilon signed a strategic collaboration agreement with the North American 100 Angel Investment
Medicilon Summary for 2023

Medicilon Summary for 2023

A Story by Medicilon


As an enabler of the pharmaceutical industry, Medicilon adheres to its original mission, works hard and moves forward resolutely, writing Medicilon's ..
Medicilon Assists Hebei Changshan Biochemical Pharmaceutical Co obtain approval for clinical researc

Medicilon Assists Hebei Changshan Biochemical Phar..

A Story by Medicilon


On January 8, 2024, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (Changshan Pharmaceutical) issued an announcement, saying that its holding su..
Empowering two pipelines with dual reporting and batching in China and the United States - Medicilon

Empowering two pipelines with dual reporting and b..

A Story by Medicilon


On January 8, Dr. Xiaobao Yang, Chairman and CEO of Gluetacs Therapeutics (Gluetacs) awarded Shanghai Medicilon Inc. (Medicilon) the "2023 Best Partne..
Gain Client Recognition Again! Medicilon won the 2023 SicaGene "Best Partner Award"

Gain Client Recognition Again! Medicilon won the 2..

A Story by Medicilon


Recently, Shanghai Medicilon Inc. (Medicilon) won the "Best Partner Award" from SicaGene. The strong support provided in collaboration projects has b..